Compare Dyne Therapeutics Inc. Common Stock (DYN) vs SMX Security Matters plc (SMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dyne Therapeutics Inc. Common Stock vs SMX Security Matters plc — how do they compare? Dyne Therapeutics Inc. Common Stock trades at $15.06 (market cap $2.86B), while SMX Security Matters plc trades at $3.85 (market cap $4.09M). The key difference: Dyne Therapeutics Inc. Common Stock is far larger — about 699.3× SMX Security Matters plc's market cap, and SMX Security Matters plc is more actively traded (108,612 versus 3,341,579). Which is the better fit depends on your goals — on Pluang, investors hold Dyne Therapeutics Inc. Common Stock for 0 Days and SMX Security Matters plc for 22 Days on average.
| DYN | SMX | |
|---|---|---|
Market Cap | $2.86B | $4.09M |
Volume | 3,341,579 | 108,612 |
Sector | Health | Industrials |
52-Week High | $26.78 | $74.08K |
52-Week Low | $14.60 | $3.56 |
Typical Hold Time | 0 Days | 22 Days |
Enterprise Value | $2.18B | -$27.23M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dyne Therapeutics (DYN) trades at $15.30, down 4.14% on the day, reflecting recent volatility amid mixed clinical trial news. The stock is in a neutral technical position with immediate support at $15 and resistance at $16. Fundamentally, the company is a clinical-stage biotech with no revenue, reporting a net loss of $446.21M in 2025, but maintains strong analyst support with an 85.7% buy rating and a $35.20 consensus price target. Recent news highlights progress in Phase 1/2 trials for neuromuscular diseases and a $375M public offering in July 2026 to fund development.
The investment case hinges on clinical success, offering significant upside to the price target, but carries high risk due to pre-revenue status, dependence on trial outcomes, and negative cash flow from operations. Investor sentiment is cautiously optimistic, buoyed by analyst confidence, though volatility from sector-specific news remains a near-term challenge.
SMX stock trades at $3.79, up 4.7% today, but faces severe fundamental challenges with no revenue reported for 2025 and a net loss of $169.18 million. The technical outlook is bearish based on moving averages, though oversold oscillators suggest potential for a near-term bounce. The company is actively promoting its Digital Material Passport technology for recycling and material verification, generating significant media coverage in outlets like Forbes and TIME as of late September 2026.
The investment case is highly speculative. While the company's technology narrative is gaining media traction, the absence of revenue and deeply negative profitability metrics present substantial risk. Investor optimism appears driven by the long-term potential of its circular economy platform rather than current financial performance, making the stock suitable only for risk-tolerant investors betting on a successful business turnaround.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Dyne Therapeutics Inc. Common Stock
Dyne Therapeutics, Inc. is a clinical-stage biotechnology company developing therapeutics for genetically driven neuromuscular diseases, including Duchenne muscular dystrophy and myotonic dystrophy type 1, with additional preclinical programs for facioscapulohumeral muscular dystrophy and Pompe disease.
Read more on DYN →About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →
